Header Logo

Connection

LANLAN SHEN to Disease Progression

Back to Details
This is a "connection" page, showing publications LANLAN SHEN has written about Disease Progression.
LANLAN SHEN
Connection Strength
0.054
Disease Progression
  1. CDC42 inhibition suppresses progression of incipient intestinal tumors. Cancer Res. 2014 Oct 01; 74(19):5480-92.
    View in: PubMed
    Score: 0.019
  2. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis. 2008 Oct; 29(10):1901-10.
    View in: PubMed
    Score: 0.012
  3. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood. 2008 Aug 15; 112(4):1366-73.
    View in: PubMed
    Score: 0.012
  4. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer. 2006 Apr 15; 106(8):1794-803.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.